Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29576 - 29600 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	FMR1NB	158521	upregulated	decitabine results in increased expression of FMR1NB mRNA	Xq27.3-q28	A21955
Decitabine	Approved Investigational	FOSL1	8061	upregulated	decitabine results in increased expression of FOSL1 mRNA	11q13.1	A21915
Decitabine	Approved Investigational	FOSL2	2355	upregulated	decitabine results in increased expression of FOSL2 mRNA	2p23.2	A21917
Decitabine	Approved Investigational	FPGS	2356	upregulated	decitabine results in increased expression of FPGS mRNA	9q34.11	A21910
Decitabine	Approved Investigational	FPR1	2357	downregulated	decitabine results in decreased expression of FPR1 mRNA	19q13.41	A21977
Decitabine	Approved Investigational	FSD1	79187	upregulated	decitabine results in increased expression of FSD1 mRNA	19p13.3	A21919
Decitabine	Approved Investigational	FST	10468	upregulated	decitabine results in increased expression of FST mRNA	5q11.2	A21919
Decitabine	Approved Investigational	FSTL1	11167	upregulated	decitabine results in increased expression of FSTL1 mRNA	3q13.33	A20985
Decitabine	Approved Investigational	FTH1	2495	upregulated	decitabine results in increased expression of FTH1 mRNA	11q12.3	A20985
Decitabine	Approved Investigational	FYN	2534	upregulated	decitabine results in increased expression of FYN mRNA	6q21	A21919 A21912
Decitabine	Approved Investigational	FZD7	8324	downregulated	decitabine results in decreased expression of FZD7 mRNA	2q33.1	A21913
Decitabine	Approved Investigational	GABARAPL1	23710	upregulated	decitabine results in increased expression of GABARAPL1 mRNA	12p13.2	A20985
Decitabine	Approved Investigational	GABARAPL3	23766	upregulated	decitabine results in increased expression of GABARAPL3 mRNA	15q26.1	A20985
Decitabine	Approved Investigational	GABRG2	2566	upregulated	decitabine results in increased expression of GABRG2 mRNA	5q34	A21915
Decitabine	Approved Investigational	GADD45A	1647	upregulated	decitabine results in increased expression of GADD45A mRNA	1p31.3	A20997 A21978
Decitabine	Approved Investigational	GAGE4	2576	upregulated	decitabine results in increased expression of GAGE4 mRNA	Xp11.4-p11.2 not on reference assembly	A21955
Decitabine	Approved Investigational	GAGE7	2579	upregulated	decitabine results in increased expression of GAGE7 mRNA	Xp11.4-p11.2 not on reference assembly	A21955
Decitabine	Approved Investigational	GAPDH	2597	upregulated	decitabine results in increased expression of GAPDH mRNA	12p13.31	A21917
Decitabine	Approved Investigational	GCH1	2643	upregulated	decitabine results in increased expression of GCH1 mRNA	14q22.2	A21912 A20985
Decitabine	Approved Investigational	GDF10	2662	upregulated	decitabine results in increased expression of GDF10 mRNA	10q11.22	A21979
Decitabine	Approved Investigational	GGT1	2678	upregulated	decitabine results in increased expression of GGT1 mRNA	22q11.23	A20985
Decitabine	Approved Investigational	GK	2710	downregulated	decitabine results in decreased expression of GK mRNA	Xp21.2	A20985
Decitabine	Approved Investigational	GLDC	2731	upregulated	decitabine results in increased expression of GLDC mRNA	9p24.1	A21912
Decitabine	Approved Investigational	GLI2	2736	downregulated	decitabine results in decreased expression of GLI2 mRNA	2q14.2	A21913
Decitabine	Approved Investigational	GMDS	2762	downregulated	decitabine results in decreased expression of GMDS mRNA	6p25.3	A20985

Displaying entries 29576 - 29600 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability